Ignite Creation Date:
2024-05-06 @ 3:31 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04652258
Status:
UNKNOWN
Last Update Posted:
2021-10-07
First Post:
2020-11-26
Brief Title:
Pyrexia Management Using an IL-6 Antibody in BRAF Melanoma Patients Treated With Dabrafenib Trametinib - Immunotherapy
Sponsor:
University of Zurich
Organization:
University of Zurich
Organization Data
Organization:
University of Zurich
Class:
OTHER
Study ID:
NovartisIIT 2020-01929
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Zurich
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None